The development of COVID-19 vaccines is moving at an unprecedented rate. Whether it takes weeks or even years for a vaccine to be approved, initial supplies will be limited. This
Since the novel coronavirus (SARS-Cov-2) was declared a pandemic last March, there have been mixed opinions about whether or not face masks can effectively slow the spread of the virus.
On August 24, Hong Kong scientists confirmed what appears to be “the first instance of human reinfection” with the novel coronavirus (SARS-Cov-2). The 33-year-old man was reinfected for a second
A new spate of studies has hinted at the possibility of “strong, lasting immunity” to the novel coronavirus (SARS-Cov-2) even after a mild COVID-19 infection. Powerful responses were observed in
On Tuesday August 11, Russia became the first country to approve a vaccine against the novel coronavirus (Sars-Cov-2). The news was announced by Russian President Vladimir Putin that the vaccine, called
People who test positive for the novel coronavirus (SARS-CoV-2) but never develop symptoms may carry as much of the virus in their nose, throat, and lungs – and for nearly
The cost of preventing future pandemics is a mere modicum of the amount Covid-19 is expected to cost the global economy, according to a new analysis published on 24 July
Two German studies published on 27 July in JAMA Cardiology have increased concerns about the potential negative impacts of COVID-19 on the heart, even in patients without underlying heart conditions.
Scientists have been working at an incredible pace to develop vaccines against the novel coronavirus (Sars-CoV-2) that causes COVID-19. Promising data from Phase I and II trials of four vaccine
There are currently 23 vaccines in human clinical trials against the novel coronavirus, SARS-CoV-2, that causes the COVID-19 infection, according to the World Health Organization (WHO). With more to come,